Team Uses GWAS to ID Biomarker for Hepatitis C Treatment Response | GenomeWeb

By Andrea Anderson

This article has been updated from a previous version to include comments from David Goldstein.

NEW YORK (GenomeWeb News) – Scientists have identified a genetic marker that they said can help predict treatment response in individuals infected with one of the most common hepatitis C virus strains.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.